TGA undertaking safety review of the allergenicity of Echinacea species.
CMA have advised that the Therapeutic Goods Administration’s Pharmacovigilance and [...]
CMA have advised that the Therapeutic Goods Administration’s Pharmacovigilance and [...]
New Regulatory Requirements Regarding Cross Border e-commerce Retail Import Operation [...]
Due to request from several stakeholders the New Zealand Ministry [...]
The Therapeutic Goods Administration has announced an increase of 2.25% [...]
The transition period for the harmonisation of medicine ingredient names [...]